DISCOUNT-ZERTIFIKAT - FRESENIUS Stock

Certificat

DE000KH2Y105

Delayed Deutsche Boerse AG 03:26:17 2024-05-28 EDT
23.91 EUR +0.08% Intraday chart for DISCOUNT-ZERTIFIKAT - FRESENIUS
Current month+1.06%
1 month+1.27%
Date Price Change
24-05-28 23.91 +0.08%
24-05-27 23.89 +0.04%
24-05-24 23.88 +0.04%
24-05-23 23.87 +0.08%
24-05-22 23.85 +0.08%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 03:26 am

More quotes

Static data

Product typeDiscount-Zertifikate
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Citi Citi
WKN KH2Y10
ISINDE000KH2Y105
Date issued 2023-01-27
Maturity 2024-06-20 (24 Days)
Parity 1 : 1
Emission price 20.26
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 23.91
Lowest since issue 19.41

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.2 EUR
Average target price
36.72 EUR
Spread / Average Target
+25.77%
Consensus